Nom du produit:tert-butyl N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetraazapentacyclo[18.5.2.1²,⁶.1¹⁰,¹⁴.0²³,²⁷]nonacosa-1(25),20,23,26-tetraen-8-yl]

IUPAC Name:tert-butyl N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetraazapentacyclo[18.5.2.1²,⁶.1¹⁰,¹⁴.0²³,²⁷]nonacosa-1(25),20,23,26-tetraen-8-yl]carbamate

CAS:2865128-10-3
Formule moléculaire:C47H65F3N8O7
Pureté:95%+
Numéro de catalogue:CM1077600
Poids moléculaire:911.08

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2865128-10-3
Formule moléculaire:C47H65F3N8O7
Point de fusion:-
Code SMILES:[H][C@]12CN(CCO1)C1=CC=C3N(CC(F)(F)F)C(=C(CC(C)(C)COC(=O)[C@]4([H])CCCN(N4)C(=O)[C@H](C2)NC(=O)OC(C)(C)C)C3=C1)C1=C(N=CC(=C1)N1CCN(CC1)C1CC1)[C@H](C)OC
Densité:
Numéro de catalogue:CM1077600
Poids moléculaire:911.08
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Morpholines
Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
morpholine price
if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.